What is the price of life and why doesn't it increase at the rate of inflation?
Publication
, Journal Article
Ubel, PA; Hirth, RA; Chernew, ME; Fendrick, AM
Published in: Archives of internal medicine
July 2003
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Archives of internal medicine
DOI
EISSN
1538-3679
ISSN
0003-9926
Publication Date
July 2003
Volume
163
Issue
14
Start / End Page
1637 / 1641
Related Subject Headings
- United States
- Risk Factors
- Quality-Adjusted Life Years
- Mass Screening
- Humans
- General & Internal Medicine
- Diabetic Retinopathy
- Diabetes Mellitus, Type 2
- Cost-Benefit Analysis
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Ubel, P. A., Hirth, R. A., Chernew, M. E., & Fendrick, A. M. (2003). What is the price of life and why doesn't it increase at the rate of inflation? Archives of Internal Medicine, 163(14), 1637–1641. https://doi.org/10.1001/archinte.163.14.1637
Ubel, Peter A., Richard A. Hirth, Michael E. Chernew, and A Mark Fendrick. “What is the price of life and why doesn't it increase at the rate of inflation?” Archives of Internal Medicine 163, no. 14 (July 2003): 1637–41. https://doi.org/10.1001/archinte.163.14.1637.
Ubel PA, Hirth RA, Chernew ME, Fendrick AM. What is the price of life and why doesn't it increase at the rate of inflation? Archives of internal medicine. 2003 Jul;163(14):1637–41.
Ubel, Peter A., et al. “What is the price of life and why doesn't it increase at the rate of inflation?” Archives of Internal Medicine, vol. 163, no. 14, July 2003, pp. 1637–41. Epmc, doi:10.1001/archinte.163.14.1637.
Ubel PA, Hirth RA, Chernew ME, Fendrick AM. What is the price of life and why doesn't it increase at the rate of inflation? Archives of internal medicine. 2003 Jul;163(14):1637–1641.
Published In
Archives of internal medicine
DOI
EISSN
1538-3679
ISSN
0003-9926
Publication Date
July 2003
Volume
163
Issue
14
Start / End Page
1637 / 1641
Related Subject Headings
- United States
- Risk Factors
- Quality-Adjusted Life Years
- Mass Screening
- Humans
- General & Internal Medicine
- Diabetic Retinopathy
- Diabetes Mellitus, Type 2
- Cost-Benefit Analysis
- 3202 Clinical sciences